Tumors in the setting of dupilumab use: A review of the literature

Tumors in the setting of dupilumab use: A review of the literature

Dupilumab is the first monoclonal antibody approved for treating moderate-to-severe atopic dermatitis (AD) and has significantly improved the quality of life of AD patients. However, the safety of dupilumab is yet unclear in the context of cancer. Therefore, we aimed to investigate the safety of dup...

Full description

Saved in:
Bibliographic Details
Main Authors: Shumeng Guo, Liangchun Wang, MD, PhD, Dingfang Bu, MD, PhD, Fengjie Liu, MD, PhD
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:World Allergy Organization Journal
Subjects:
Dupilumab
Atopic dermatitis
Tumor
Cutaneous T-cell lymphomas
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455124001388
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items